Michael Kauffman
Chairman bei BIVICTRIX THERAPEUTICS PLC
Vermögen: 88 462 $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Chen Schor | M | 51 |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | 15 Jahre |
Christopher Kirk | M | 52 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 14 Jahre |
Dan Paterson | M | 63 | 13 Jahre | |
Aya Jakobovits | M | 71 | 10 Jahre | |
Daniel Calkins | M | 37 | 6 Jahre | |
Richard Paulson | M | 56 | 4 Jahre | |
Adi Raviv | M | 69 |
Mirror Biologics Inc
Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | - |
Brian Stuglik | M | 64 | 7 Jahre | |
Tiffany Thorn | F | 37 | 8 Jahre | |
Amy Kruse | F | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 4 Jahre |
John Fowler | M | 52 | 9 Jahre | |
Michael Ehlers | M | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.
The Johns Hopkins University School of Medicine
| 8 Jahre |
Eric Rowinsky | M | 67 |
The Johns Hopkins University School of Medicine
| 16 Jahre |
Carl Gordon | M | 59 | 9 Jahre | |
Graham Cooper | M | 54 | 7 Jahre | |
Mike Hickey | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 3 Jahre |
Barry Greene | M | 60 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 14 Jahre |
Robert Gagnon | M | 49 | 6 Jahre | |
Christy Oliger | F | 54 | 4 Jahre | |
Accumanno James | M | - | 3 Jahre | |
Dakin Sloss | M | 33 |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 6 Jahre |
Elizabeth Garner | M | 56 | 5 Jahre | |
Jeffrey Chodakewitz | M | 68 | 4 Jahre | |
Richard Gaynor | M | 74 | 4 Jahre | |
Robert Hawkins | M | 69 | 3 Jahre | |
Michael Mano | M | 47 | 4 Jahre | |
Sohanya Cheng | F | 41 | 3 Jahre | |
Courtney Wallace | F | 40 | 3 Jahre | |
Spiros Liras | M | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | - |
Clifford Brangwynne | M | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | - |
Brad Pruente | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 3 Jahre |
Katie Peng | F | - | 1 Jahre | |
Micki Klearman | M | 69 | 3 Jahre | |
Michelle Robertson | F | 57 | 3 Jahre | |
Mansoor Mirza | M | 63 | 14 Jahre | |
Paul Bunn | M | 79 | 3 Jahre | |
Andrew Sinclair | M | 52 | 3 Jahre | |
Cathy Carew | F | - | - | |
John Johnson | M | 66 | 4 Jahre | |
William Paris | M | 73 | 3 Jahre | |
Brian Harvey | M | 63 | 4 Jahre | |
Garen Bohlin | M | 76 | 11 Jahre | |
Marc Belsky | M | 68 | 6 Jahre | |
David W. Beier | M | 75 | 6 Jahre | |
Mike Mason | M | 49 | 5 Jahre | |
Franklin Berger | M | 74 | 8 Jahre | |
Susan Lowther | F | 65 | 3 Jahre | |
Christie Iacomini | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 3 Jahre |
Anne Bowdidge | F | - | - | |
Steve Dubin | M | 70 | 4 Jahre | |
Michael Har-Noy | M | - |
Mirror Biologics Inc
Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | 5 Jahre |
Anil Kapur | M | 54 | 2 Jahre | |
Deepa Pakianathan | M | 59 | 11 Jahre | |
Stuart Poulton | M | 51 | 2 Jahre | |
Stylianos Kyriacou | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 5 Jahre |
Simone D'Amico | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 5 Jahre |
Nicolette McIver | F | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 3 Jahre |
Lee Wah Yeo | F | - |
Mirror Biologics Inc
Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | - |
Blake Scholl | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
Henry W. Mahncke | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
JJ Moi | F | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 6 Jahre |
Jennifer Roberts | F | - | 7 Jahre | |
Aaron Mandell | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
Neil Renninger | M | 49 |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
Taneli Jouhikainen | M | 57 |
Mirror Biologics Inc
Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | - |
Stephen Harper | M | 64 |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
Kam Ghaffarian | M | 65 |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | - |
Tahsinul Huque | M | 56 |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 3 Jahre |
Pritha Ghosh | M | - |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paul Brannelly | M | 51 | 4 Jahre | |
Sharon Shacham | M | 53 | 13 Jahre | |
Justin Renz | M | 52 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 11 Jahre |
Robert M. Forrester | M | 60 | 8 Jahre | |
Alexis Borisy | M | 52 |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 9 Jahre |
Joseph Chiapponi | M | 55 | 6 Jahre | |
Ian Smith | M | 58 |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | 13 Jahre |
Michael J. Todisco | M | 59 | - | |
Joseph Araujo | M | 50 | 2 Jahre | |
Amit Munshi | M | 56 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | - |
Oren M. Becker | M | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | 1 Jahre |
Ronald DePinho | M | 69 | 4 Jahre | |
Susan Molineaux | M | 70 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | 6 Jahre |
Jean-Pierre Sommadossi | M | 68 | 7 Jahre | |
Kenneth E. Weg | M | 85 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 7 Jahre |
John Scarlett | M | 73 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | - |
Jim O'Shea | M | 74 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 7 Jahre |
Richard H. Aldrich | M | 69 | 4 Jahre | |
Sally Crawford | F | 70 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | 7 Jahre |
Mark Corrigan | M | 66 |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | 5 Jahre |
Lisa Meletta | F | - | - | |
Samuel Agresta | M | 51 | 5 Jahre | |
S. Phanstiel | F | 65 | 6 Jahre | |
Brian Sullivan | M | - | 9 Jahre | |
Peter Honig | M | 67 | 2 Jahre | |
Giulio Draetta | M | - | - | |
Jeffrey Berkowitz | M | 58 | 6 Jahre | |
José Baselga | M | 65 | 3 Jahre | |
Stephen Kraus | M | 47 | 2 Jahre | |
Ansbert Gadicke | M | 66 | 2 Jahre | |
Madelyn Zeylikman | F | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 96 | 96,00% |
Vereinigtes Königreich | 4 | 4,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Kauffman
- Persönliches Netzwerk